UPDATE: MLV Reiterates Buy on Novavax, Reduces PT to $9.50

Symbols: NVAX
Tags: MLV
Share

MLV reiterated its Buy rating on Novavax (NASDAQ: NVAX). At the same time, the rating agency reduced its price target on the company's stock from $11 to $9.50. On Thursday, NVAX closed the day at $1.33.


 
 
< Previous
Credit Suisse Upgrading Edison International (EIX) OUTPERFORM D. Eggers
Next >
Morgan Keegan Initiates RailAmerica At Outperform, $20 PT
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust